Blonanserin vs Risperidone in Japanese Patients With Schizophrenia: A Post Hoc Analysis of a Phase 3, 8‐week, Multicenter, Double‐blind, Randomized Controlled Study
Neuropsychopharmacology Reports - United States
doi 10.1002/npr2.12089
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2019
Authors
Publisher
Wiley